1 not yet recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Adjuvant Immunotherapy: new trials by email Literature Review of Adjuvant Immunotherapy trials Research Report on Adjuvant Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base Neoadjuvant chemoimmunotherapy, Tislelizumab Nab paclitaxel - Head and Neck Cancer Squamous Cell Carcinoma, Skull Base--Cancer | Phase 2 | Not yet recruiting | Sun Yat-sen University | 24 | 2025-09-20 | 2025-08-28 |
| Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC endoscopic surgery - Recurrent Nasopharyngeal Carcinoma | Phase 2 | Unknown | Eye & ENT Hospital of Fudan University | 77 | 2022-05-08 | 2022-05-10 |
Eye & ENT Hospital of Fudan University (1) · Sun Yat-sen University (1)
China (2)
Hongmeng Yu, MD,PHD (1) · Yujie Liang (1)
PMID 15825201, PMID 18486742, PMID 18784101, PMID 23129742, PMID 27718784, PMID 30509740, PMID 31679945, PMID 33243985, PMID 34473219, PMID 35585121, PMID 35766967, PMID 37395170, PMID 37991778, PMID 38110599, PMID 38467604